1. Please check and comment entries here.
Table of Contents

    Topic review

    SLC11A2 Gene

    View times: 11
    Submitted by: Karina Chen
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    solute carrier family 11 member 2

    1. Normal Function

    The SLC11A2 gene provides instructions for making a protein called divalent metal transporter 1 (DMT1). Four different versions (isoforms) of the DMT1 protein are produced from the SLC11A2 gene. Each isoform is specific to one or more tissues, but some form of the DMT1 protein is found in all tissues. The primary role of the DMT1 protein is to transport positively charged iron atoms (ions) within cells; however, the protein can transport some other metal ions as well.

    In a section of the small intestine called the duodenum, the DMT1 protein is located within finger-like projections called microvilli. These projections absorb nutrients from food as it passes through the intestine and then release them into the bloodstream. In all other cells, including immature red blood cells called erythroblasts, DMT1 is located in the membrane of endosomes, which are specialized compartments that are formed at the cell surface to carry proteins and other molecules to their destinations within the cell. DMT1 transports iron from the endosomes to the cytoplasm so it can be used by the cell.

    2. Health Conditions Related to Genetic Changes

    2.1. Hypochromic microcytic anemia with iron overload

    At least seven mutations in the SLC11A2 gene have been found to cause hypochromic microcytic anemia with iron overload. This condition is characterized by a shortage of red blood cells (anemia) that is apparent at birth. The red blood cells that are produced are abnormally small (microcytic) and pale (hypochromic). There is also progressive accumulation of iron in the liver.

    Most SLC11A2 gene mutations that cause this condition change single protein building blocks (amino acids) in the DMT1 protein. These mutations lead to reduced production of the DMT1 protein, decreased protein function, or impaired ability of the protein to get to the correct location in cells. In erythroblasts, a shortage of DMT1 protein diminishes the amount of iron transported within cells, even though there is an abundance of iron in the blood. As a result, the development of healthy red blood cells is impaired, leading to a shortage of these cells. In the duodenum, a shortage of DMT1 protein decreases iron absorption. To compensate, cells increase production of functional DMT1 protein, which increases iron absorption. Because the red blood cells cannot use the iron that is absorbed, it accumulates in the liver, eventually impairing liver function. The lack of iron in red blood cells and the accumulation of iron in the liver lead to the signs and symptoms of hypochromic microcytic anemia with iron overload.

    3. Other Names for This Gene

    • DCT1
    • divalent cation transporter 1
    • DMT-1
    • DMT1
    • natural resistance-associated macrophage protein 2
    • NRAMP 2
    • NRAMP2
    • solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
    • solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2

    This entry is adapted from https://medlineplus.gov/genetics/gene/slc11a2

    References

    1. Bardou-Jacquet E, Island ML, Jouanolle AM, Détivaud L, Fatih N, Ropert M,Brissot E, Mosser A, Maisonneuve H, Brissot P, Loréal O. A novel N491S mutationin the human SLC11A2 gene impairs protein trafficking and in association with theG212V mutation leads to microcytic anemia and liver iron overload. Blood CellsMol Dis. 2011 Dec 15;47(4):243-8. doi: 10.1016/j.bcmd.2011.07.004.
    2. Beaumont C, Delaunay J, Hetet G, Grandchamp B, de Montalembert M, Tchernia G. Two new human DMT1 gene mutations in a patient with microcytic anemia, lowferritinemia, and liver iron overload. Blood. 2006 May 15;107(10):4168-70.
    3. Iolascon A, De Falco L. Mutations in the gene encoding DMT1: clinicalpresentation and treatment. Semin Hematol. 2009 Oct;46(4):358-70. doi:10.1053/j.seminhematol.2009.06.005. Review.
    4. Lam-Yuk-Tseung S, Camaschella C, Iolascon A, Gros P. A novel R416C mutation inhuman DMT1 (SLC11A2) displays pleiotropic effects on function and causesmicrocytic anemia and hepatic iron overload. Blood Cells Mol Dis. 2006May-Jun;36(3):347-54.
    5. Mims MP, Prchal JT. Divalent metal transporter 1. Hematology. 2005Aug;10(4):339-45. Review.
    6. Priwitzerova M, Nie G, Sheftel AD, Pospisilova D, Divoky V, Ponka P.Functional consequences of the human DMT1 (SLC11A2) mutation on proteinexpression and iron uptake. Blood. 2005 Dec 1;106(12):3985-7.
    7. Shawki A, Knight PB, Maliken BD, Niespodzany EJ, Mackenzie B. H(+)-coupleddivalent metal-ion transporter-1: functional properties, physiological roles and therapeutics. Curr Top Membr. 2012;70:169-214. doi:10.1016/B978-0-12-394316-3.00005-3. Review.
    More

    Keywords